IFG
SLS icon

Independent Financial Group’s SELLAS Life Sciences SLS Stock Holding History

Independent Financial Group’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$295K Buy
24,000
+750
+3% +$9.39K 0.01% 1268
2026
Q2 		$343K Hold
23,250
– – 0.01% 1173
2026
Q1 		$98.3K Hold
23,250
– – ﹤0.01% 1423
2025
Q4 		$87.7K Hold
23,250
– – ﹤0.01% 1386
2025
Q3 		$37.4K Hold
23,250
– – ﹤0.01% 1350
2025
Q2 		$50.9K Hold
23,250
– – ﹤0.01% 1276
2025
Q1 		$25.1K Hold
23,250
– – ﹤0.01% 1164
2024
Q4 		$24.2K Hold
23,250
– – ﹤0.01% 1150
2024
Q3 		$29.1K Hold
23,250
– – ﹤0.01% 1118
2024
Q2 		$27.7K Buy
23,250
+3,000
+15% +$4.08K ﹤0.01% 1076
2024
Q1 		$20.5K Hold
20,250
– – ﹤0.01% 1009
2023
Q4 		$21.5K Buy
20,250
+4,600
+29% +$4.98K ﹤0.01% 942
2023
Q3 		$25.7K Buy
15,650
+3,000
+24% +$4.73K ﹤0.01% 890
2023
Q2 		$19.9K Buy
+12,650
New +$20.3K ﹤0.01% 870

Other funds holding SLS

EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
EM
ELCO Management New York $213M AUM 25.23% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $271M AUM
FD
Financial Designs Claremont, California $194M AUM 10.52% 1-Year Est. Return
FFBTD
First Financial Bank - Trust Division Hamilton, Ohio $1.39B AUM 15.59% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Independent Financial Group's SLS Position: Q3 2026 in Review

Independent Financial Group increased its SELLAS Life Sciences (SLS) stake by 3.2% in Q3 2026, buying an estimated $9.39K and bringing the position to 24,000 shares worth $295K. The position accounts for 0.01% of the portfolio, ranked #1268.

Independent Financial Group first reported a position in SLS in Q2 2023 and has held it in 14 quarters since. The position peaked at $343K in Q2 2026. 12 funds tracked by Wall St. Rank hold SLS as of Q3 2026.

  • Independent Financial Group held 24,000 shares of SELLAS Life Sciences worth $295K as of Q3 2026.
  • Independent Financial Group bought 750 SELLAS Life Sciences shares in Q3 2026, an estimated $9.39K.
  • SELLAS Life Sciences made up 0.01% of Independent Financial Group's portfolio in Q3 2026, its #1268 holding.
  • Independent Financial Group first reported a position in SELLAS Life Sciences in Q2 2023 and has held it in 14 quarters since.
  • Independent Financial Group's SELLAS Life Sciences position peaked at $343K in Q2 2026.
  • 12 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.

Based on Independent Financial Group's 13F filing for Q3 2026, filed 13 Oct 2026.